CERVICAL SPONDYLOSIS TREATMENT MARKET ANALYSIS

Market News

Recent Developments

New product launches/approvals

• In September 2023, ZimVie Inc., a global life sciences leader in the dental and spine markets, announced that the U.S. Food and Drug Administration (FDA) approved its Mobi-C Cervical Disc Hybrid Investigational Device Exemption (IDE) application. The decision authorizes ZimVie to begin enrolling U.S. patients in the study, which will follow patients who receive simultaneous Cervical Disc Arthroplasty (CDA) and Anterior Cervical Discectomy and Fusion (ACDF) at adjacent levels between C3 and C7.
• In February 2019, Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced the U.S. Food and Drug Administration (FDA) approval of the M6-C artificial cervical disc for patients suffering from cervical disc degeneration

Acquisition and partnerships

• In 2020, Stryker, a global medical technology company, announced the acquisition of Wright Medical Group N.V., a leading provider of orthopedic medical devices. This acquisition expanded Stryker's product portfolio and expertise in the spinal surgery market including the treatment of cervical spondylosis.
• In 2021, the American Association of Neurological Surgeons (AANS) and the American Academy of Orthopaedic Surgeons (AAOS) announced that Medtronic, a global leader in medical technology, has become the latest industrial sponsor of the American Spine Registry. With the same objective of enhancing patient care, Medtronic's sponsorship of the ASR expands on its dedication to developing the science of spine care and enhancing the results of spine surgery.
• In August 2023, ZimVie Inc., a global life sciences company in the dental and spine markets, announced that it has expanded its collaboration agreement with Brainlab, a spine imaging, planning, and navigation portfolio leader with robotic imaging, surgical assistance, and mixed reality to support spinal surgeries